Osteoporosis Trial, Recruiting (NCT06395883)

Osteoporosis Trial, Recruiting NCT06395883 Sponsor: Diakonhjemmet Hospital Condition: Osteoporosis

Printed from Voxsanity (voxsanity.com.au) — NCT06395883 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoporosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with an inflammatory rheumatic joint disease (a condition where the immune system causes painful swelling in the joints, such as rheumatoid arthritis)
You are about to start a disease-modifying treatment (medication that slows down the disease) with or without steroid tablets/injections, OR you are already on a stable disease-modifying treatment and are receiving steroid injections directly into a muscle or vein

Who may not be able to join:

You have already been diagnosed with osteoporosis (weak, brittle bones) or are currently being treated for it
You are a woman going through the menopausal transition (confirm with trial site)
You are currently taking oestrogen (a hormone treatment)
You have had a bone fracture at any point in the last year
You are on long-term, ongoing steroid (glucocorticoid) treatment
You have received any steroid (glucocorticoid) treatment within the last year before joining the trial
You currently have active cancer
You have kidney failure or severely reduced kidney function

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4747957020

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06395883

Sponsor: Diakonhjemmet Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Osteoporosis

Trial contact: +4747957020

More information: https://clinicaltrials.gov/study/NCT06395883

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with an inflammatory rheumatic joint disease (a condition where the immune system causes painful swelling in the joints, such as rheumatoid arthritis)
You are about to start a disease-modifying treatment (medication that slows down the disease) with or without steroid tablets/injections, OR you are already on a stable disease-modifying treatment and are receiving steroid injections directly into a muscle or vein

Who may not be able to join:

You have already been diagnosed with osteoporosis (weak, brittle bones) or are currently being treated for it
You are a woman going through the menopausal transition (confirm with trial site)
You are currently taking oestrogen (a hormone treatment)
You have had a bone fracture at any point in the last year
You are on long-term, ongoing steroid (glucocorticoid) treatment
You have received any steroid (glucocorticoid) treatment within the last year before joining the trial
You currently have active cancer
You have kidney failure or severely reduced kidney function

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Diakonhjemmet Hospital

Registry

ClinicalTrials.gov

Start date

1 January 2025

Est. completion

1 June 2026

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

P1NP level 3 months after glucocorticoid termination

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov